Anika Therapeutics, Inc. (ANIK)
15.02
-0.12
(-0.79%)
USD |
NASDAQ |
May 21, 16:00
15.00
-0.02
(-0.13%)
After-Hours: 19:59
Anika Therapeutics Research and Development Expense (TTM) : 26.42M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 187.06M |
| Elutia, Inc. | 5.732M |
| Plus Therapeutics, Inc. | 9.488M |
| Perspective Therapeutics, Inc. | 77.61M |
| AVITA Medical, Inc. | 20.18M |